ZTS (ZTS) Stock Analysis

ZTS (ZTS) is a publicly traded company in the HEALTHCARE sector. It trades at $76.38, carries a market capitalization of $32.52B, a price-to-earnings ratio of 12.71, a dividend yield of 0.03%. This page summarizes the public market data, fundamentals, and frequently asked questions for ZTS, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NYSE

Key Metrics

• Price: $76.38
• Market Cap: $32.52B
• P/E Ratio: 12.71
• EPS: $6.10
• Dividend Yield: 0.03%
• 52-Week High: $168.90
• 52-Week Low: $72.38

Market Sentiment

ZTS currently has a Bearish sentiment score of -0.45.

About ZTS

Zoetis Inc. (ZTS) is a leading global animal health company dedicated to improving the health and well-being of livestock and companion animals. As the largest manufacturer of medicines and vaccines for animals, Zoetis leverages advanced research and development to offer a comprehensive range of innovative products that enhance productivity in animal agriculture and support the well-being of pets globally. Committed to sustainability and animal welfare, Zoetis is well-positioned to meet the i...

GNG Research Analysis

GNG Research scores ZTS (ZTS) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for ZTS.

Frequently Asked Questions

What is ZTS's current dividend yield?

ZTS (ZTS) has a current dividend yield of 0.03%.

Does ZTS pay dividends?

Yes, ZTS pays dividends with a current yield of 0.03%.

What is ZTS's P/E ratio?

ZTS has a price-to-earnings (P/E) ratio of 12.71.

What is ZTS's market cap?

ZTS (ZTS) has a market capitalization of $32.52B with a current stock price of $76.38.